These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31150809)

  • 21. Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.
    Vacca O; El Mathari B; Darche M; Sahel JA; Rendon A; Dalkara D
    J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
    Apaolaza PS; Del Pozo-Rodríguez A; Solinís MA; Rodríguez JM; Friedrich U; Torrecilla J; Weber BH; Rodríguez-Gascón A
    Biomaterials; 2016 Jun; 90():40-9. PubMed ID: 26986855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-sealing hyaluronic acid-coated 30-gauge intravitreal injection needles for preventing vitreous and drug reflux through needle passage.
    Eom Y; Kim S; Huh J; Koh MY; Hwang JY; Kang B; Li X; Lee MS; Lee H; Kim HM; Song JS
    Sci Rep; 2021 Aug; 11(1):16996. PubMed ID: 34417529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina.
    Huang D; Chen YS; Rupenthal ID
    Mol Pharm; 2017 Feb; 14(2):533-545. PubMed ID: 27997199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and Evaluation of Polymer-Based Nanoparticles for Intravitreal Gene-Delivery Applications.
    Lee D; Kwak G; Johnson TV; Suk JS
    Curr Protoc; 2022 Dec; 2(12):e607. PubMed ID: 36469609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal nanoparticles for retinal delivery.
    Huang X; Chau Y
    Drug Discov Today; 2019 Aug; 24(8):1510-1523. PubMed ID: 31102730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers.
    Pitkänen L; Ruponen M; Nieminen J; Urtti A
    Pharm Res; 2003 Apr; 20(4):576-83. PubMed ID: 12739764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug micro-carriers with a hyaluronic acid corona toward a diffusion-limited aggregation within the vitreous body.
    Mayol L; Silvestri T; Fusco S; Borzacchiello A; De Rosa G; Biondi M
    Carbohydr Polym; 2019 Sep; 220():185-190. PubMed ID: 31196539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical Disruption of the Inner Limiting Membrane In Vivo Enhances Targeting to the Inner Retina.
    Do JL; Pedroarena-Leal N; Louie M; Avila Garcia P; Alnihmy A; Patel A; Weinreb RN; Wahlin KJ; La Torre Vila A; Welsbie DS
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):25. PubMed ID: 38117244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization.
    Lee J; Ryoo NK; Han H; Hong HK; Park JY; Park SJ; Kim YK; Sim C; Kim K; Woo SJ; Park KH; Kim H
    Mol Pharm; 2016 Jun; 13(6):1988-95. PubMed ID: 27173745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.
    Sanders NN; Peeters L; Lentacker I; Demeester J; De Smedt SC
    J Control Release; 2007 Oct; 122(3):226-35. PubMed ID: 17574287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of system A in the retina-to-blood transport of l-proline across the inner blood-retinal barrier.
    Yoneyama D; Shinozaki Y; Lu WL; Tomi M; Tachikawa M; Hosoya K
    Exp Eye Res; 2010 Apr; 90(4):507-13. PubMed ID: 20074566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryonic synthesis of the inner limiting membrane and vitreous body.
    Halfter W; Dong S; Schurer B; Ring C; Cole GJ; Eller A
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2202-9. PubMed ID: 15914642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posterior vitreous detachment with plasmin in the isolated human eye.
    Li X; Shi X; Fan J
    Graefes Arch Clin Exp Ophthalmol; 2002 Jan; 240(1):56-62. PubMed ID: 11954782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
    Kim H; Robinson SB; Csaky KG
    Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
    Vacca O; Darche M; Schaffer DV; Flannery JG; Sahel JA; Rendon A; Dalkara D
    Glia; 2014 Mar; 62(3):468-76. PubMed ID: 24382652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations.
    Thakur SS; Shenoy SK; Suk JS; Hanes JS; Rupenthal ID
    Eur J Pharm Biopharm; 2020 Mar; 148():118-125. PubMed ID: 31981693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.